F J Dudley, R A Fox, S Sherlock. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Acute DiseaseAge FactorsAntibody FormationCarcinoma, Hepatocellular/immunologyCarrier State/immunologyChronic DiseaseComplement Fixation TestsComplement System Proteins/analysisFemaleHepatitis/drug therapyHepatitis/immunologyHepatitis A/immunologyHepatitis B Antigens/analysisHepatitis B virus/immunologyHumansHypersensitivity, DelayedImmunity, CellularImmunodiffusionImmunoelectrophoresisImmunosuppressive Agents/pharmacologyLiver Neoplasms/immunologyMalePrednisone/pharmacologyPrednisone/therapeutic useSex FactorsTransaminases/blood
Substances: See more » Hepatitis B AntigensImmunosuppressive AgentsComplement System ProteinsTransaminasesPrednisone
Year: 1971 PMID: 4103666 DOI: 10.1016/s0140-6736(71)90001-8
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321